Abh Healthcare Limited
Minimum investment
Bidding date
24 Aug - 27 Aug 2026
Price range
₹96 - ₹102
Minimum quantity
2,400
Minimum investment
₹1,15,200
Issue size
₹35 Cr.
IPO doc (link)
RHP docsListing exchange
NSE/BSE
Total Issue Size:
₹35 Crore
Fresh Issue: 94% (₹33 Cr)
OFS: 0% (₹0 Cr)
Fresh Issue – ₹33 Crore
Offer for Sale – ₹0 Crore
Before Issue: 100%
After Issue: 69.99%
Lock-in / Stabilization | Timeline |
|---|---|
Minimum Promoters' Contribution | 3 Years |
50% of Promoters' Holding above Minimum Promoters' Contribution | 2 Years |
Remaining 50% of Promoters' Holding above Minimum Promoters' Contribution | 1 Year |
Pre-IPO Shares held by Non-Promoters | 1 Year |
Note: Retail IPO investors have no lock-in and can sell shares from the listing day.
Incorporated in 2021, ABH Healthcare Ltd. operates Anil Baghi Hospital, a 150-bed healthcare facility offering medical and surgical services across 25 specialties. Its areas of treatment include cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT and maxillofacial surgeries.
The company has established relationships with 30 private and public health insurance providers and third-party administrators. It also provides healthcare services under government and institutional schemes such as ECHS, Railways, FCI, BSNL and Ayushman Bharat–Sarbat Sehat Bima Yojana.
As of June 30, 2026, ABH Healthcare had 37 doctors and 101 nurses. The company is led by promoters Kamal Baghi, Saurabh Baghi and Vaishali Saini.
Financially, the company reported total income of Rs. 52.59 crore in FY2026, compared with Rs. 49.32 crore in FY2025. Profit after tax increased to Rs. 5.64 crore from Rs. 5.35 crore during the same period.
Established Multi-Specialty Healthcare Facility: ABH Healthcare operates a 150-bed hospital providing treatment across 25 medical specialties. This diversified service portfolio allows the company to cater to patients requiring different types of medical and surgical care.
Diversified Patient and Insurance Network: The company is empaneled with 30 private and public insurance providers and TPAs. Its participation in government and institutional healthcare schemes provides additional channels for patient access and revenue generation.
Experienced Clinical Team: As of June 30, 2026, the hospital had 37 doctors and 101 nurses. The company's doctor-led management structure and focus on experienced clinicians support its ability to deliver specialized healthcare services.
Improving Financial Performance: ABH Healthcare's total income increased from Rs. 49.32 crore in FY2025 to Rs. 52.59 crore in FY2026, while PAT rose from Rs. 5.35 crore to Rs. 5.64 crore. EBITDA also increased from Rs. 13.20 crore to Rs. 14.72 crore.
IPO Proceeds to Reduce Borrowings: The company plans to use Rs. 17 crore of the issue proceeds towards repayment or prepayment of certain borrowings. Reducing debt could help lower financial obligations and improve the company's balance-sheet position.
High Debt Levels: The company had total borrowings of Rs. 45.75 crore as of March 31, 2026, compared with a net worth of Rs. 17.27 crore. Its debt-to-equity ratio stood at 3.20, indicating significant reliance on borrowings.
Concentration in a Single Hospital: ABH Healthcare's operations are centred around its Anil Baghi Hospital. Any major disruption caused by operational issues, regulatory changes, infrastructure problems or other unforeseen events could have a material impact on the company's business.
Healthcare Business Requires Continuous Investment: Hospital operations require regular spending on medical equipment, technology, infrastructure and qualified healthcare professionals. Maintaining and upgrading these facilities can increase operating and capital expenditure.
Competitive Healthcare Market: The company operates in a competitive healthcare industry where it faces competition from other hospitals and healthcare providers. Patient preferences, pricing, reputation, quality of treatment and availability of specialised doctors can influence its ability to attract and retain patients.
Acquisition Plans Are Not Yet Identified: Part of the IPO proceeds is proposed to be used for inorganic growth through unidentified acquisitions and general corporate purposes. Since specific acquisition targets have not been identified, the eventual outcome and benefits from this portion of the funds remain uncertain.
52.59 Cr.
Mar'26
5.64 Cr.
Mar'26
14.72 Cr.
Mar'26
57 investors voted
Active IPOs | |
|---|---|
Company name | Bid starts |
Tempsens Instruments India | 20-08-2026 |
Augmont Enterprises | 21-08-2026 |
Hy Tech Engineers | 24-08-2026 |
Skyways Air Services | 24-08-2026 |
Symbiotec Pharmalab | 24-08-2026 |
Abh Healthcare | 24-08-2026 |
Madhur Knit Crafts | 24-08-2026 |
Sumax Engineering | 25-08-2026 |